Stay updated on Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0. This is a metadata update and does not alter the study details.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding/status notice related to NIH operations. The study details, eligibility criteria, and contact information on the page remain unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedThe update appears to adjust page layout and formatting without altering key study details such as eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange Detected- Added a government funding lapse notice with operating status guidance for NIH Clinical Center and links to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed the previous v3.1.0 version tag.SummaryDifference5%

- Check78 days agoChange DetectedUpdated Melanoma topic tagging to a broader entry and refreshed contact and revision details (added new phone numbers, email, and Revision v3.1.0; removed older Melanoma label and Revision v3.0.2).SummaryDifference0.7%

- Check93 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' link/button has been removed.SummaryDifference0.3%

Stay in the know with updates to Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.